This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lincoln, T. Articles by Conklin, T. J. Search for Related Content PubMed Articles by Lincoln, T. Articles by Conklin, T. J. Social Bookmarking                         What's this?

Skin Anergy Testing and Tuberculosis Surveillance

Baystate Medical Center, Hampden County Correctional Center, and Tufts University School of Medicine in Springfield and Ludlow, MA; Brightwood Health Center, 380 Plainfield Street, Springfield, MA 01107, Phone: (413) 784-8375, tlincoln{at}library.bhs.org

Virginia Lynch, RN

Thomas J. Conklin, MD

Hampden County Correctional Center in Ludlow, MA

Our objective was to assess the utility of the addition of delayed latent type hypersensitivity antigens (anergy testing) to purified protein derivative (PPD) tuberculin skin testing on intake to a correctional facility. We conducted a retrospective review of a two and a half year period during which new inmates were skin tested with PPD, Candida albicans, and mumps antigens by the Mantoux method. Of the 11,514 tested, 7.0 percent had prior PPD positive test results, 4.2 percent were new PPD positive, and 6.6 percent were anergic. HIV prevalence was 6 percent. Three active cases of tuberculosis were found. No benefit from anergy skin testing was found in this jail population.

Journal of Correctional Health Care, Vol. 4, No. 2, 139-153 (1997)
DOI: 10.1177/107834589700400204


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?